DaVita’s Q2 adjusted EPS surpassed estimates, but shares fell as 2026 guidance remained steady at $14.10-$15.20.
DaVita (DVA) reported Q2 financial results that exceeded expectations on both revenue and earnings, yet shares declined approximately 7% in after-hours trading. The company maintained its 2026 adjusted diluted EPS guidance at $14.10-$15.20, with consensus estimates at $14.88.
Analysts had anticipated stronger forward-looking signals, but the unchanged outlook may have disappointed investors. The Q2 non-GAAP EPS also beat estimates, though the market reaction suggests concerns over growth prospects or execution risks.
The stock’s decline reflects investor focus on future performance rather than past results, despite the earnings beat.